Affective disorders accompanied by cognitive disorders in inpatients with cardiovascular diseases: a clinical and pathopsychological study
- Authors: Mashkova I.Y.1, Aleshkina G.A.1, Vasyuk Y.A.1, Bardenshteyn L.M.1, Samushiya M.A.2
-
Affiliations:
- Russian University of Medicine
- Central State Medical Academy of Department of Presidential Affairs
- Issue: Vol 31, No 4 (2025)
- Pages: 322-330
- Section: Original Research Articles
- URL: https://bakhtiniada.ru/0869-2106/article/view/313407
- DOI: https://doi.org/10.17816/medjrf678932
- EDN: https://elibrary.ru/YJKIHA
- ID: 313407
Cite item
Abstract
BACKGROUND: The multimorbidity of affective, cognitive, and cardiovascular diseases is an urgent issue of the contemporary medicine due to their severity, resistance to therapy, social maladjustment, and low quality of life. Common pathogenetic mechanisms, including endothelial dysfunction and disorders of the frontal and subcortical connections, enhance these conditions, increasing the risks of dementia and mortality.
AIM: To study the clinical and psychopathological structure of affective disorders and comorbid cognitive disorders in inpatients with cardiovascular diseases in various age groups.
METHODS: An observational, single-center study was conducted from January 2023 to June 2024 at the University Clinic of the Russian University of Medicine. The study involved 121 patients with cardiovascular diseases and non-psychotic mental disorders, including 47 (38.8%) with comorbid affective and cognitive disorders. The patients were divided into three age groups, 45–59, 60–74, and 75–90 years. Clinical psychopathological and psychometric (Hospital Anxiety and Depression Scale, Montreal Cognitive Assessment) and neuropsychological methods (clock drawing test, Luria’s method) were used. Statistical analysis was performed using Fisher’s exact test and Student’s t-test.
RESULTS: In 85.1% of patients, we detected organic emotional disorders, mainly with alarming symptoms. Significant differences in the clinical structure of affective disorders between the groups indicate age-related differences (p = 0.045). Cognitive disorders (visual and constructional praxis, attention, memory, abstract thinking) are associated with vascular changes and dysfunction of the frontal lobes. The Montreal Cognitive Assessment scores were in the range of 18–27; the average score in the 45–59 group (24.9 ± 0.3) was higher compared to the 60–74 (23.5 ± 0.2; p < 0.05) and 75–90 groups (23.4 ± 0.3; p < 0.05). Moderate cognitive disorders were detected in 55.3% of cases, severe cognitive disorders were detected in 19.2% of cases, and 25.5% of cases were within the normal range. Subjective cognitive complaints related to the risk of dementia were not confirmed by tests in 27.6% of cases. Attention and abstract thinking disorders increased with age (p < 0.05); whereas speech disorders showed no significant differences (p > 0.05).
CONCLUSION: The study highlights the importance of early diagnosis and an interdisciplinary approach to multimorbid conditions and a qualitative analysis of the psychopathological and pathopsychological structure of affective and cognitive disorders in cardiovascular cases. The limitation is the small sample size, requiring further research on a larger sample of patients.
Full Text
##article.viewOnOriginalSite##About the authors
Irina Yu. Mashkova
Russian University of Medicine
Author for correspondence.
Email: mashkovairina2018@gmail.com
ORCID iD: 0000-0002-4342-671X
SPIN-code: 5929-7530
MD, Cand. Sci. (Medicine), Associate Professor
Russian Federation, 4 Dolgorukovskaya st, Моscow, 127006Galina A. Aleshkina
Russian University of Medicine
Email: aleshkina-ga@yandex.ru
ORCID iD: 0000-0001-7028-8669
SPIN-code: 7477-8598
MD, Dr. Sci. (Medicine), Professor
Russian Federation, 4 Dolgorukovskaya st, Моscow, 127006Yuri A. Vasyuk
Russian University of Medicine
Email: yvasyuk@yandex.ru
ORCID iD: 0000-0003-1296-941X
SPIN-code: 2265-5331
MD, Dr. Sci. (Medicine), Professor
Russian Federation, 4 Dolgorukovskaya st, Моscow, 127006Leonid M. Bardenshteyn
Russian University of Medicine
Email: barden@mail.ru
ORCID iD: 0000-0002-1171-5517
SPIN-code: 9289-9177
MD, Dr. Sci. (Medicine), Professor
Russian Federation, 4 Dolgorukovskaya st, Моscow, 127006Marina A. Samushiya
Central State Medical Academy of Department of Presidential Affairs
Email: sma-psychiatry@mail.ru
ORCID iD: 0000-0003-3681-9977
SPIN-code: 8196-3652
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, МоscowReferences
- Bardenstein LM, Torchinov AM, Umakhanova MM, Kharkharova MA. Clinical typology of depressive disorders in women during the perimenopausal period. Allergolodgy and Immunolodgy. 2005;6(2):269–275. (In Russ.) EDN: DBKIVC
- Bobrov AE, Starostina EG, Agamamedova IN, et al. Mental disorders in type 2 diabetes. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7):22–30. doi: 10.17116/jnevro202112107122 EDN: TXIPKK
- Vasyuk YA, Dovzhenko TV, Dubrovskaya TI, et al. Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders. Terapevticheskii arkhiv. 2021;93(1):94–99. doi: 10.26442/00403660.2021.01.200567 EDN: BQIZGW
- Birk JL, Kronish IM, Moise N, et al. Depression and multimorbidity: considering temporal characteristics of the associations between depression and multiple chronic diseases. Health Psychol. 2019;38(9):802–811. doi: 10.1037/hea0000737 EDN: ECBMNJ
- Matskevich SA, Belskaya MI. Comorbidity of cardiovascular diseases and anxiety-depressive disorders. Meditsinskie novosti. 2018;(12):4–8. EDN: VSCWNW
- Koyanagi A, Köhler-Forsberg O, Benros ME, et al. Mortality in unipolar depression preceding and following chronic somatic diseases. Acta Psychiatr Scand. 2018;138(6):500–508. doi: 10.1111/acps.12899
- Sobennikov VS, Vinokurov EV, Rychkova LV, Sobennikova VV. Emotional dysregulation as a factor of psychosomatic disturbances in depression and cardiovascular pathology (analytical review of foreign literature). Acta Biomed Sci. 2019;4(1):87–92. doi: 10.29413/ABS.2019-4.1.13 EDN: ISABDC
- Willmott R, Martin West I, et al. An investigation of neuropsychiatric symptoms, contextual factors, and antidepressant treatment as risk factors for dementia development in people with mild cognitive impairment. Int J Geriatr Psychiatry. 2024;39(5):e6097. doi: 10.1002/gps.6097
- Ostroumova OD, Parfenov VA, Ostroumova TM, et al. Expert consensus. Effect of antihypertensive therapy on cognitive functions. Systemic hypertension. 2021;18(1):5–12. doi: 10.26442/2075082X.2021.1.200575 EDN: EXNFNY
- Scuteri A, Benetos A, Sierra C, et al. Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how — a decision-making support from the working group on 'hypertension and the brain' of the European Society of Hypertension and from the European Geriatric Medicine Society. J Hypertens. 2021;39(1):90–100. doi: 10.1097/HJH.0000000000002621
- Krupenin PM, Voskresenskaya ON, Napalkov DA, Sokolova AA. Cognitive impairment and small vessel disease in atrial fibrillation. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(6):55–62. doi: 10.14412/2074-2711-2022-6-55-62 EDN: WTVQPS
- Brown R, Benveniste H, Black SE, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res. 2018;114(11):1462–1473. doi: 10.1093/cvr/cvy113
- Passiak BS, Liu D, Kresge HA, et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers. Neurology. 2019;92(12):e1309–1321. doi: 10.1212/WNL.0000000000007124
- Neznanov NG, Ivanov MV. Negative and cognitive disorders in endogenous psychoses: diagnosis, clinical features, therapy. 2nd ed. Moscow: MEDpress-inform; 2023. 328 p. (In Russ.)
- Ostroumova OD, Ostroumova TM, Dzamikhov KK. Arterial hypertension and cognitive impairment: multimodal approach for patient care and nicergoline use. Medical Council. 2020;(8):72–80. doi: 10.21518/2079-701X-2020-8-72-80 EDN: HLOEZH
- Petrova NN. Depression in the structure of various mental disorders and cognitive impairment. Psikhiatriya, psikhoterapiya i klinicheskaya psikhologiya. 2024;15(4):442–451. doi: 10.34883/PI.2024.15.4.001 EDN: FIKWWW
- Gerschmann A, Lehrner J. Depressive symptoms: not a predictor for five-year mortality in patients with subjective cognitive decline, non-amnestic and amnestic mild cognitive impairment. Neuropsychiatr. 2024;38(3):135–144. doi: 10.1007/s40211-024-00495-2
- Zakharov VV. Cognitive impairment no dementia: classification, major causes, and treatment. Effective Pharmacotherapy. 2016;(1):22–31. EDN: VORKLV
- Bogolepova AN. Vascular depression and cognitive dysfunction. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(S3):26–31. doi: 10.14412/2074-2711-2019-3S-26-31 EDN: LIDMXI
- Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–852. doi: 10.1016/j.jalz.2014.01.001
- Cao Q, Tan CC, Xu W, et al. The prevalence of dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2020;73(3):1157–1166. doi: 10.3233/JAD-191092
- Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. doi: 10.1016/j.jalz.2012.11.007
- Golland VB, Dmitrieva TB, Kazakovtsev BA, et al. Mental disorders and behavioral disorders (F00-F99). (Class V ICD-10, adapted for use in the Russian Federation). Kazakovtsev BA, Golland VB, editors. Moscow; 1998. 512 p. (In Russ.)
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x
- Bogolepova AN, Vasenina EE, Gomzyakova NA, et al. Clinical guidelines for cognitive disorders in elderly and older patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10-3):6–137. doi: 10.17116/jnevro2021121103 EDN: MPUDYF
- Agrell B, Dehlin O. The clock-drawing test. 1998. Age Ageing. 2012;41(Suppl. 3):iii41–45. doi: 10.1093/ageing/afs149
- Rubinshtein SY. Experimental methods of pathopsychology and their clinical application. Moscow: April-Press; 2010. 224 p. (In Russ.) EDN: QLXITH
- Bardenstein LM. Clinic, dynamics, and therapy of dysthymia. In: Aleksandrovsky YA, Bardenstein LM, Avedisova AS. Psychopharmacotherapy of borderline mental disorders. Moscow; 2000. P. 136–163. (In Russ.)
- Yakhno NN, Zakharov VV, Lokshina AB. Moderate cognitive impairment syndrome in cerebral vascular insufficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2005;105(2):13–17. EDN: HRXPHZ
- Fehnel SE, Forsyth BH, DiBenedetti DB, et al. Patient-centered assessment of cognitive symptoms of depression. CNS Spectr. 2016;21(1):43–52. doi: 10.1017/S1092852913000643
- Hammar A, Lund A, Hugdahl K. Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study. Psychiatry Res. 2003;118(2):189–196. doi: 10.1016/s0165-1781(03)00075-1
- Vasenina EE, Levin OS. Speech disorders in vascular and neurodegenerative diseases: potentials for medication and non-drug therapy. Pharmateca. 2020;27(3):38–49. doi: 10.18565/pharmateca.2020.3.38-49 EDN: JJFHWY
- Voznesenskaya TG. Non-cognitive neuropsychiatric disorders in cognitive impairments in the elderly. Neurological Journal. 2010;15(2):4–18. (In Russ.) EDN: MRMMQP
Supplementary files
